NPs Basic Information

Name
Decanoic acid
Molecular Formula C10H20O2
IUPAC Name*
decanoic acid
SMILES
CCCCCCCCCC(=O)O
InChI
InChI=1S/C10H20O2/c1-2-3-4-5-6-7-8-9-10(11)12/h2-9H2,1H3,(H,11,12)
InChIKey
GHVNFZFCNZKVNT-UHFFFAOYSA-N
Synonyms
Decanoic acid; CAPRIC ACID; 334-48-5; n-Decanoic acid; n-Capric acid; Decoic acid; Decylic acid; Caprinic acid; n-Decylic acid; 1-Nonanecarboxylic acid; Caprynic acid; n-Decoic acid; Hexacid 1095; NSC 5025; FEMA No. 2364; C10:0; Lead caprate; Emery 659; MFCD00004441; 4G9EDB6V73; CHEBI:30813; caprynate; decoate; decylate; NSC-5025; n-caprate; n-decoate; n-decylate; NCGC00091320-02; 1-nonanecarboxylate; Decanoic acid anion; DSSTox_CID_1554; DSSTox_RID_76208; DSSTox_GSID_21554; DKA; Econosan Acid Sanitizer; Decanoic acid (natural); Versatic 10; CAS-334-48-5; CCRIS 4610; HSDB 2751; EINECS 206-376-4; EPA Pesticide Chemical Code 128955; BRN 1754556; UNII-4G9EDB6V73; Dekansaeure; Kaprinsaeure; AI3-04453; 1-decanoic acid; nonanecarboxylic acid; Nat. Decanoic Acid; Prifrac 296; Prifac 296; Decanoic acid, 96%; Prifac 2906; Decanoic acid-[13C]; Nonane-1-carboxylic acid; Lunac 10-95; Lunac 10-98; bmse000370; CAPRIC ACID [INCI]; SCHEMBL2682; WLN: QV9; DECANOIC ACID [FCC]; N-CAPRIC ACID [MI]; DECANOIC ACID [FHFI]; DECANOIC ACID [HSDB]; 4-02-00-01041 (Beilstein Handbook Reference); Decanoic acid, >=98.0%; MLS002415724; CH3-[CH2]8-COOH; PRIFAC-2906; (1(1)(3)C)Decanoic acid; CHEMBL107498; GTPL5532; PALMAC-99-10; DTXSID9021554; N-CAPRIC ACID [WHO-DD]; Decanoic acid, lead (2+) salt; NSC5025; Decanoic acid, analytical standard; HMS2267B15; ZINC1529229; Decanoic acid, >=98.0% (GC); Tox21_113533; Tox21_202209; Tox21_300366; LMFA01010010; s6906; STL445666; Decanoic acid, >=98%, FCC, FG; AKOS000119623; CS-W016025; DB03600; HY-W015309; NCGC00091320-01; NCGC00091320-03; NCGC00091320-04; NCGC00091320-05; NCGC00254437-01; NCGC00259758-01; AS-14704; BP-27911; FA(10:0); SMR001252255; SY061635; D0017; Decanoic acid, natural, >=98%, FCC, FG; FT-0665532; FT-0665533; EN300-19724; C01571; D70225; A875289; Q422613; W-202368; CAPRIC ACID (CONSTITUENT OF SAW PALMETTO) [DSC]; Z104474944; B1334-066368; 98230577-0D20-4F70-B532-00AC60132CFE; 1-(S)- cis 9-Aminooctahydro-10-oxo-6H-pyridazino[1,2-a][1,2]diazepine-1-carboxylic acid, t-butyl ester
CAS 334-48-5
PubChem CID 2969
ChEMBL ID CHEMBL107498
*Note: the IUPAC Name was collected from PubChem.
Chemical Classification:
  • Kingdom: Organic compounds
    • Superclass: Lipids and lipid-like mol
      • Class: Fatty Acyls
        • Subclass: Fatty acids and conjugate
          • Direct Parent: Medium-chain fatty acids

ClassyFire Version 1.0
PMID:27867422

NPs Species Source

Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference
Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference

NPs Content

*Note: The vaules in Content Percentage are calculated by dividing the content value by the maximum content value in NP Content.
**Note: The units with different NP content, due to their incomparable values, are separated into different tables.

NPs Biological Activity

Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name
Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name

NPs Physi-Chem Properties

Molecular Weight: 172.26 ALogp: 4.1
HBD: 1 HBA: 2
Rotatable Bonds: 8 Lipinski's rule of five: Accepted
Polar Surface Area: 37.3 Aromatic Rings: 0
Heavy Atoms: 12 QED Weighted: 0.562

NPs ADMET Properties*

ADMET: Absorption

Caco-2 Permeability: -4.849 MDCK Permeability: 0.00003220
Pgp-inhibitor: 0.043 Pgp-substrate: 0.001
Human Intestinal Absorption (HIA): 0.005 20% Bioavailability (F20%): 0.87
30% Bioavailability (F30%): 0.965

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB): 0.773 Plasma Protein Binding (PPB): 94.37%
Volume Distribution (VD): 0.265 Fu: 4.51%

ADMET: Metabolism

CYP1A2-inhibitor: 0.084 CYP1A2-substrate: 0.397
CYP2C19-inhibitor: 0.028 CYP2C19-substrate: 0.627
CYP2C9-inhibitor: 0.118 CYP2C9-substrate: 0.975
CYP2D6-inhibitor: 0.008 CYP2D6-substrate: 0.117
CYP3A4-inhibitor: 0.008 CYP3A4-substrate: 0.036

ADMET: Excretion

Clearance (CL): 2.688 Half-life (T1/2): 0.795

ADMET: Toxicity

hERG Blockers: 0.02 Human Hepatotoxicity (H-HT): 0.039
Drug-inuced Liver Injury (DILI): 0.044 AMES Toxicity: 0.006
Rat Oral Acute Toxicity: 0.071 Maximum Recommended Daily Dose: 0.018
Skin Sensitization: 0.453 Carcinogencity: 0.122
Eye Corrosion: 0.981 Eye Irritation: 0.988
Respiratory Toxicity: 0.527
*Note: the ADMET properties was calculated by ADMETlab 2.0. Reference: PMID: 33893803.

Similar Compounds*

Compounds similar to EMNPD with top10 similarity:

Similar NPs Similar Drugs
NPs ID NPs 2D Structure Similarity Score TTD ID Drug 2D Structure Similarity Score
ENC000270 0.917 D0Z5BC 0.683
ENC000263 0.909 D0E4WR 0.581
ENC000102 0.846 D0XN8C 0.533
ENC000030 0.818 D0O1PH 0.500
ENC000265 0.737 D0FD0H 0.500
ENC000722 0.737 D0O1TC 0.477
ENC000378 0.733 D07ILQ 0.453
ENC000466 0.688 D03ZJE 0.438
ENC000593 0.683 D0I4DQ 0.437
ENC000556 0.683 D0UE9X 0.429
*Note: the compound similarity was calculated by RDKIT.